Correlation Between Centessa Pharmaceuticals and Israel Acquisitions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Israel Acquisitions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Israel Acquisitions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Israel Acquisitions Corp, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Israel Acquisitions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Israel Acquisitions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Israel Acquisitions.

Diversification Opportunities for Centessa Pharmaceuticals and Israel Acquisitions

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Centessa and Israel is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Israel Acquisitions Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Israel Acquisitions Corp and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Israel Acquisitions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Israel Acquisitions Corp has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Israel Acquisitions go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Israel Acquisitions

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 3.17 times more return on investment than Israel Acquisitions. However, Centessa Pharmaceuticals is 3.17 times more volatile than Israel Acquisitions Corp. It trades about 0.09 of its potential returns per unit of risk. Israel Acquisitions Corp is currently generating about 0.02 per unit of risk. If you would invest  770.00  in Centessa Pharmaceuticals PLC on September 14, 2024 and sell it today you would earn a total of  915.00  from holding Centessa Pharmaceuticals PLC or generate 118.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Israel Acquisitions Corp

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Israel Acquisitions Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Israel Acquisitions Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Israel Acquisitions is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Centessa Pharmaceuticals and Israel Acquisitions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Israel Acquisitions

The main advantage of trading using opposite Centessa Pharmaceuticals and Israel Acquisitions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Israel Acquisitions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Israel Acquisitions will offset losses from the drop in Israel Acquisitions' long position.
The idea behind Centessa Pharmaceuticals PLC and Israel Acquisitions Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data